Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.
about
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsAdoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis.A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosusCyclic GMP-AMP Synthase Is Required for Cell Proliferation and Inflammatory Responses in Rheumatoid Arthritis Synoviocytes.Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.
P2860
Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Type I IFNs as biomarkers in r ...... ing and personalized medicine.
@en
type
label
Type I IFNs as biomarkers in r ...... ing and personalized medicine.
@en
prefLabel
Type I IFNs as biomarkers in r ...... ing and personalized medicine.
@en
P2860
P356
P1433
P1476
Type I IFNs as biomarkers in r ...... ling and personalized medicine
@en
P2093
Ana Suárez
Patricia López
P2860
P304
P356
10.1042/CS20140554
P407
P577
2015-04-01T00:00:00Z